Effects of Three Cytokine Regimens on Hematologic Recovery and Progenitor Cell Mobilization after High-Dose Cyclophosphamide, Etoposide, and Cisplatin

Publisher： Karger

E-ISSN： 1423-0232|59|1|7-13

ISSN： 0030-2414

Source： Oncology, Vol.59, Iss.1, 2000-06, pp. : 7-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant Chemotherapy with High-Dose Cyclophosphamide, Etoposide and Cisplatin Intensification without Progenitor Cell Support in Breast Cancer Patients with Ten or More Involved Nodes: 5-Year Results of a Pilot Trial

By  

Oncology, Vol. 60, Iss. 3, 2001-04 ,pp. : 221-227

Karger

Access to resources Recommend Favorite

High-Dose Cyclophosphamide Therapy Associated with Diffuse Alveolar Hemorrhage after Allogeneic Hematopoietic Stem Cell Transplantation

By  

Respiration, Vol. 86, Iss. 6, 2012-12 ,pp. : 453-461

Karger

Access to resources Recommend Favorite

Cytoreduction and Stem Cell Mobilization with a Regimen of Paclitaxel, Etoposide and Cyclophosphamide Followed by Autologous Transplantation Using a Preparative Regimen of Busulfan, Etoposide and Cyclophosphamide for Patients with Advanced Lymphoma

By  

Acta Haematologica, Vol. 105, Iss. 4, 2001-08 ,pp. : 222-232

Karger

Access to resources Recommend Favorite

Infections after T‐replete haploidentical transplantation and high‐dose cyclophosphamide as graft‐versus‐host disease prophylaxis

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 2, 2015-04 ,pp. : 242-249

John Wiley & Sons Inc

Access to resources Recommend Favorite

A low‐dose regimen of cisplatin before high‐dose cisplatin potentiates ototoxicity

By  

THE LARYNGOSCOPE, Vol. 125, Iss. 2, 2015-02 ,pp. : E78-E83

John Wiley & Sons Inc

Access to resources Recommend Favorite